Merck Serono names three grant winners

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MERCK SERONO awarded its first Grant for Oncology Innovation, who will receive grants totaling EUR 1 million. The grant supports researchers focused on personalized treatment of solid tumors.

The 2014 winners were formally announced at the annual meeting of the European Society for Medical Oncology in Madrid. They are:

Clara Montagut, of Hospital del Mar, in Barcelona, Spain; for proposed research on ultra-selection and molecular monitoring of CRC patients treated with anti-EGFR therapy using NGS platforms and serial liquid biopsies.

Stefan Sleijfer, of the Erasmus MC Cancer Institute, in Rotterdam, Netherlands; for proposed research on non-invasive monitoring of breast cancer therapy using cell-free tumor DNA in blood.

Ulrich Güller, of Cantonal Hospital, in St. Gallen, Switzerland; for a prospective, double-blinded, placebo-controlled, phase III randomized trial of adjuvant aspirin treatment in PIK3CA mutated colon cancer patients.

Table of Contents

YOU MAY BE INTERESTED IN

Credit: Jonah Elkowitz/ShutterstockThat President Biden was diagnosed with prostate cancer is certainly unfortunate news, but it should come as no surprise. One in eight men in the U.S. will be told they have prostate cancer at some point in their lifetime: more than 300,000 new diagnoses occur annually, and the absolute numbers are rising. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login